Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis

Abstract

Objective Cerebral atrophy is a correlate of clinical progression in multiple sclerosis (MS). Mitochondria are now established to play a part in the pathogenesis of MS. Uniquely, mitochondria harbor their own mitochondrial DNA (mtDNA), essential for maintaining a healthy central nervous system. We explored mitochondrial respiratory chain activity and mtDNA deletions in single neurons from secondary progressive MS (SPMS) cases. Methods Ninety‐eight snap‐frozen brain blocks from 13 SPMS cases together with complex IV/complex II histochemistry, immunohistochemistry, laser dissection microscopy, long‐range and real‐time PCR and sequencing were used to identify and analyze respiratory‐deficient neurons devoid of complex IV and with complex II activity. Results The density of respiratory‐deficient neurons in SPMS was strikingly in excess of aged controls. The majority of respiratory‐deficient neurons were located in layer VI and immediate subcortical white matter (WM) irrespective of lesions. Multiple deletions of mtDNA were apparent throughout the gray matter (GM) in MS. The respiratory‐deficient neurons harbored high levels of clonally expanded mtDNA deletions at a single‐cell level. Furthermore, there were neurons lacking mtDNA‐encoded catalytic subunits of complex IV. mtDNA deletions sufficiently explained the biochemical defect in the majority of respiratory‐deficient neurons. Interpretation These findings provide evidence that neurons in MS are respiratory‐deficient due to mtDNA deletions, which are extensive in GM and may be induced by inflammation. We propose induced multiple deletions of mtDNA as an important contributor to neurodegeneration in MS. Ann Neurol 2010

Shown for reading. Its publisher allows quoting it, not republishing it.

References 46

1. 1.

   Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain. 1989;112((pt 6)):1419-1428.

   Not in our library10.1093/brain/112.6.1419

2. 2.

   Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol. 2008;64:255-265.

   Not in our library10.1002/ana.21436

3. 3.

   Fisniku LK, Chard DT, Jackson JS, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol. 2008;64:247-254.

   Not in our library10.1002/ana.21423

4. 4.

   Dutta R, Trapp BD. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology. 2007;68:S22-S31.

   Not in our library10.1212/01.wnl.0000275229.13012.32

5. 5.

   Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006;52:61-76.

   Not in our library10.1016/j.neuron.2006.09.011

6. 6.

   Dutta R, McDonough J, Yin X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol. 2006;59:478-489.

   Not in our library10.1002/ana.20736

7. 7.

   Kalman B, Laitinen K, Komoly S. The involvement of mitochondria in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2007;188:1-12.

   Not in our library10.1016/j.jneuroim.2007.03.020

8. 8.

   Mahad DJ, Ziabreva I, Campbell G, et al. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009;132:1161-1174.

   Not in our library10.1093/brain/awp046

9. 9.

   Witte ME, Bo L, Rodenburg RJ, et al. Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol. 2009;219:193-204.

   Not in our library10.1002/path.2582

10. 10.

    Lu F, Selak M, O'Connor J, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci. 2000;177:95-103.

    Not in our library10.1016/s0022-510x(00)00343-9

11. 11.

    Krieger C, Duchen MR. Mitochondria, Ca2+ and neurodegenerative disease. Eur J Pharmacol. 2002;447:177-188.

    Not in our library10.1016/s0014-2999(02)01842-3

12. 12.

    Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005;6:389-402.

    Not in our library10.1038/nrg1606

13. 13.

    DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348:2656-2668.

    Not in our library10.1056/nejmra022567

14. 14.

    Zeviani M, Di, Donato S. Mitochondrial disorders. Brain. 2004;127:2153-2172.

    Not in our library10.1093/brain/awh259

15. 15.

    Tanji K, Bonilla E. Optical imaging techniques (histochemical, immunohistochemical, and in situ hybridization staining methods) to visualize mitochondria. Methods Cell Biol. 2007;80:135-154.

    Not in our library10.1016/s0091-679x(06)80006-3

16. 16.

    Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787-795.

    Not in our library10.1038/nature05292

17. 17.

    Reeve AK, Krishnan KJ, Turnbull D. Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann N Y Acad Sci. 2008;1147:21-29.

    Not in our library10.1196/annals.1427.016

18. 18.

    Kraytsberg Y, Kudryavtseva E, McKee AC, et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006;38:518-520.

    Not in our library10.1038/ng1778

19. 19.

    Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;17:1195-1214.

    Not in our library10.1096/fj.02-0752rev

20. 20.

    Druzhyna NM, Wilson GL, LeDoux SP. Mitochondrial DNA repair in aging and disease. Mech Ageing Dev. 2008;129:383-390.

    Not in our library10.1016/j.mad.2008.03.002

21. 21.

    Krishnan KJ, Reeve AK, Samuels DC, et al. What causes mitochondrial DNA deletions in human cells? Nat Genet. 2008;40:275-279.

    Not in our library10.1038/ng.f.94

22. 22.

    Bender A, Schwarzkopf RM, McMillan A, et al. Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol. 2008;255:1231-1235.

    Not in our library10.1007/s00415-008-0892-9

23. 23.

    Bua E, Johnson J, Herbst A, et al. Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am J Hum Genet. 2006;79:469-480.

    Not in our library10.1086/507132

24. 24.

    Nicholas A, Kraytsberg Y, Guo X, Khrapko K. On the timing and the extent of clonal expansion of mtDNA deletions: evidence from single-molecule PCR. Exp Neurol. 2009;218:316-319.

    Not in our library10.1016/j.expneurol.2009.04.029

25. 25.

    Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001;50:389-400.

    Not in our library10.1002/ana.1123

26. 26.

    Bo L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003;62:723-732.

    Not in our library10.1093/jnen/62.7.723

27. 27.

    Krishnan KJ, Bender A, Taylor RW, Turnbull DM. A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells. Anal Biochem. 2007;370:127-129.

    Not in our library10.1016/j.ab.2007.06.024

28. 28.

    Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38:515-517.

    Not in our library10.1038/ng1769

29. 29.

    Chang A, Smith MC, Yin X, et al. Neurogenesis in the chronic lesions of multiple sclerosis. Brain. 2008;131:2366-2375.

    Not in our library10.1093/brain/awn157

30. 30.

    Reeve AK, Krishnan KJ, Elson JL, et al. Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet. 2008;82:228-235.

    Not in our library10.1016/j.ajhg.2007.09.018

31. 31.

    Krishnan KJ, Greaves LC, Reeve AK, Turnbull D. The ageing mitochondrial genome. Nucleic Acids Res. 2007;35:7399-7405.

    Not in our library10.1093/nar/gkm635

32. 32.

    Oldfors A, Moslemi AR, Fyhr IM, et al. Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol. 1995;54:581-587.

    Not in our library10.1097/00005072-199507000-00012

33. 33.

    Santorelli FM, Sciacco M, Tanji K, et al. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol. 1996;39:789-795.

    Not in our library10.1002/ana.410390615

34. 34.

    Cooper CE, Brown GC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr. 2008;40:533-539.

    Not in our library10.1007/s10863-008-9166-6

35. 35.

    Elfering SL, Haynes VL, Traaseth NJ, et al. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2004;286:H22-H29.

    Not in our library10.1152/ajpheart.00766.2003

36. 36.

    Wei J, Guo H, Kuo PC. Endotoxin-stimulated nitric oxide production inhibits expression of cytochrome c oxidase in ANA-1 murine macrophages. J Immunol. 2002;168:4721-4727.

    Not in our library10.4049/jimmunol.168.9.4721

37. 37.

    Betts J, Lightowlers RN, Turnbull DM. Neuropathological aspects of mitochondrial DNA disease. Neurochem Res. 2004;29:505-511.

    Not in our library10.1023/b:nere.0000014821.07269.8d

38. 38.

    Trevelyan AJ, Kirby DM, Smulders-Srinivasan TK, et al. Mitochondrial DNA mutations affect calcium handling in differentiated neurons. Brain. 2010;133(pt 3):787-796.

    Not in our library10.1093/brain/awq023

39. 39.

    Micu I, Jiang Q, Coderre E, et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature. 2006;439:988-992.

    Not in our library10.1038/nature04474

40. 40.

    Nicholls DG, Budd SL, Ward MW, Castilho RF. Excitotoxicity and mitochondria. Biochem Soc Symp. 1999;66:55-67.

    Not in our library10.1042/bss0660055

Cited by papers we hold 15

• In defence of ferroptosis · 2025
  No notice
• Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics · 2022
  No notice
• Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders · 2021
  No notice
• The Cuprizone Model: Dos and Do Nots · 2020
  No notice
• The rise and rise of mitochondrial DNA mutations · 2020
  No notice
• Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis · 2019
  No notice
• Mechanisms of neurobehavioral abnormalities in multiple sclerosis: Contributions from neural and immune components · 2019
  Not checked
• Retraction Note: Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis · 2019
  Not checked
• Mitochondrial Dysfunction and Multiple Sclerosis · 2019
  No notice
• Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options · 2019
  No notice
• Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders · 2019
  No notice
• Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments · 2017
  No notice
• Multiple sclerosis: experimental models and reality · 2016
  No notice
• Myelin damage and repair in pathologic CNS: challenges and prospects · 2015
  No notice
• Ageing and Parkinson's disease: Why is advancing age the biggest risk factor? · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.